Tempus Labs News Today

Tempus AI filed with the Securities and Exchange Commission (SEC) on Monday to raise up to $100M in an initial public offering (IPO).

Personalis, Inc. , a leader in advanced genomics for precision oncology, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided recent business...

New York, February 21, 2024: Select companies in the pharmaceutical, semiconductor and information technology industries are pushing innovation at a remarkable pace, while new advances in the automotive industry are also driving innovation, according to new data measuring patent quality and quantity. LexisNexis® Legal & Professional, a leading global provider of information and analytics, today released the third edition of its…

Exclusive arrangement will expand market access to Personalis’ ultra-sensitive MRD test ...

Scaling up means having more power to bring to bear on core activities.

Sixty business trade associations representing a broad range of industries signed on to a letter to the Hill today urging lawmakers to support a Congressional Review Act resolution.

SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Recursion RXRX, a leading clinical stage TechBio company decoding biology to industrialize drug discovery,…

Despite his short career in Washington, Mike Johnson does have some close allies on K Street.

MONDAY, Oct. 9, 2023 (HealthDay News) -- For a subset of patients with advanced lung cancer, radiation therapy can sometimes substantially extend their lives.

Measuring ctDNA levels before radiotherapy predicted PFS and overall survival, and can help determine the patients most likely to benefit from consolidation radiotherapy vs systemic therapy.